UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009280 |
|---|---|
| Receipt number | R000010902 |
| Scientific Title | A Phase II Study of Bi-weekly XELIRI with Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy |
| Date of disclosure of the study information | 2012/11/07 |
| Last modified on | 2019/12/19 15:47:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/07 17:14:20 | ||
| 2 | Update | 2012/11/07 17:22:47 | Institute Institute Organization Organization |
|
| 3 | Update | 2013/04/26 12:11:38 | Interventions/Control_1 Interventions/Control_1 |
|
| 4 | Update | 2013/11/07 09:43:52 | Email |
|
| 5 | Update | 2015/11/07 09:38:19 | Recruitment status |
|
| 6 | Update | 2016/05/07 09:17:25 | Name of primary person or sponsor Organization |
|
| 7 | Update | 2019/11/11 09:21:04 | UMIN ID1 |
|
| 8 | Update | 2019/11/11 09:25:03 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2019/11/11 09:44:27 | Publication of results Number of participants that the trial has enrolled Results Results date posted Date of the first journal publication of results |
|
| 10 | Update | 2019/11/11 09:46:25 | Recruitment status Date of IRB Last follow-up date |
|
| 11 | Update | 2019/12/19 15:08:33 | UMIN ID2 |
|
| 12 | Update | 2019/12/19 15:47:22 | UMIN ID3 |
